TRACON Pharmaceuticals, Inc. (TCON) Financials

$0.03

south_east
-$0 (0%)
Day's range
$0.03
Day's range
$0.04

TCON Income statement / Annual

Last year (2023), TRACON Pharmaceuticals, Inc.'s total revenue was $12.05 M, and the percentage change from the previous year is not available. In 2023, TRACON Pharmaceuticals, Inc.'s net income was -$3.59 M. See TRACON Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $12.05 M $0.00 $346,000.00 $0.00 $0.00 $3.00 M $8.76 M $3.45 M $7.90 M $3.60 M
Cost of Revenue $14,000.00 $16,000.00 $14,000.00 $12,000.00 $22,000.00 $30.46 M $19.36 M $15.24 M $20.43 M $4.85 M
Gross Profit $12.03 M -$16,000.00 $332,000.00 -$12,000.00 -$22,000.00 -$27.46 M -$10.60 M -$11.80 M -$12.53 M -$1.26 M
Gross Profit Ratio 1 0 0.96 0 0 -9.15 -1.21 -3.42 -1.58 -0.35
Research and Development Expenses $12.28 M $13.89 M $11.15 M $8.20 M $14.53 M $30.46 M $19.36 M $21.57 M $25.68 M $7.65 M
General & Administrative Expenses $6.67 M $14.01 M $17.55 M $8.03 M $7.77 M $7.28 M $7.61 M $7.86 M $5.69 M $2.13 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $6.67 M $14.01 M $17.55 M $8.03 M $7.77 M $7.28 M $7.61 M $7.86 M $5.69 M $2.13 M
Other Expenses $0.00 -$1.24 M -$320,000.00 -$7,000.00 -$378,000.00 $12,000.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $18.93 M $27.89 M $28.69 M $16.22 M $22.30 M $37.74 M $26.97 M $29.43 M $31.37 M $9.78 M
Cost And Expenses $18.94 M $27.89 M $28.69 M $16.22 M $22.30 M $37.74 M $26.97 M $29.43 M $31.37 M $9.78 M
Interest Income $0.00 $994,000.00 $318,000.00 $545,000.00 $386,000.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $7.30 M $994,000.00 $318,000.00 $545,000.00 $386,000.00 $231,000.00 $886,000.00 $1.12 M $923,000.00 $667,000.00
Depreciation & Amortization $14,000.00 $16,000.00 $14,000.00 $12,000.00 $22,000.00 $28,000.00 $48,000.00 $94,000.00 $51,000.00 $15,000.00
EBITDA -$6.88 M -$27.89 M -$28.33 M -$16.22 M -$22.27 M -$34.71 M -$18.17 M -$25.80 M -$23.42 M -$6.16 M
EBITDA Ratio -0.57 0 -81.93 0 0 -11.58 -1.98 -7.23 -2.85 -1.54
Operating Income Ratio -0.57 0 -81.93 0 0 -11.58 -2.08 -7.53 -2.97 -1.72
Total Other Income/Expenses Net $3.31 M -$1.24 M -$320,000.00 -$552,000.00 -$378,000.00 -$219,000.00 -$893,000.00 -$1.03 M -$943,000.00 -$630,000.00
Income Before Tax -$3.59 M -$29.14 M -$28.67 M -$16.78 M -$22.67 M -$34.96 M -$19.10 M -$27.01 M -$24.41 M -$6.81 M
Income Before Tax Ratio -0.3 0 -82.85 0 0 -11.65 -2.18 -7.83 -3.09 -1.89
Income Tax Expense $0.00 $177,000.00 $59,000.00 $551,000.00 -$16,000.00 $12,000.00 $845,000.00 $938,000.00 $892,000.00 $615,000.00
Net Income -$3.59 M -$29.31 M -$28.73 M -$17.33 M -$22.66 M -$34.96 M -$19.10 M -$27.01 M -$24.41 M -$6.81 M
Net Income Ratio -0.3 0 -83.02 0 0 -11.65 -2.18 -7.83 -3.09 -1.89
EPS -2.2 -28.02 -33.3 -38.63 -149.35 -259.47 -227.33 -426.06 -439.2 -113.7
EPS Diluted -2.19 -28.02 -33.3 -38.57 -149.35 -259.47 -227.33 -426.06 -439.2 -113.7
Weighted Average Shares Out $1.63 M $1.05 M $862,632.00 $448,529.00 $151,715.00 $134,731.00 $84,033.00 $63,390.00 $55,578.00 $59,887.00
Weighted Average Shares Out Diluted $1.64 M $1.05 M $862,632.00 $449,207.00 $151,715.00 $134,731.00 $84,033.00 $63,390.00 $55,578.00 $59,887.00
Link